The risk of adverse events was higher in the SCS plus HIPEC group compared to the SCS group, although the difference did not reach statistical significance (RR = 1.42, 95% CI [1.00, 2.01], Fig. 3 A).
← all excerpts
Efficacy and safety of secondary cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in platinum-sensitive recurrent ovarian cancer: a systematic review and meta-analysis.
1
—
—